Recapitulating the orthotopic tumour microenvironment using bioluminescent syngeneic models in immune competent mice for checkpoint inhibitor interrogation

被引：0
|
作者：
Papadopoulou, N. [1 ]
Davies, J. [1 ]
Wainwright, L. [1 ]
Wrigley, J. [1 ]
Jiang, S. [1 ]
King, J. [1 ]
Yin, Y. [1 ]
Kumari, J. [1 ]
机构：
[1] Crown Biosci UK Ltd, Oncol, Loughborough, Leics, England
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
329 (PB-09
引用
收藏
页码：E109 / E110
页数：2
相关论文
共 44 条
  • [1] Recapitulating the orthotopic tumor microenvironment using bioluminescent syngeneic models in immune competent mice for checkpoint inhibitor interrogation
    Obeng, Joyce Afrakoma
    Jetha, Maya
    Wrigley, Jane
    Jiang, Simon
    King, Jason
    Kumari, Rajendra
    Yin, Yinfei
    CANCER RESEARCH, 2019, 79 (13)
  • [2] Evaluation of tumour infiltrating immune cells into the orthotopic and metastatic tumour microenvironment using bioluminescent syngeneic cell line models in immune competent mice following treatment with checkpoint inhibitors
    Andrew, M.
    Nektaria, P.
    Simon, J.
    Jane, W.
    Jason, K.
    Vicky, L.
    Kelly, J.
    Russell, G.
    Neil, W.
    Kumari, R.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S111 - S111
  • [3] Check point inhibitor modulation of tumor microenvironment at orthotopic and metastatic sites using bioluminescent syngeneic cell line models in immune competent mice
    McKenzie, Andrew
    Papadopoulou, Nektaria
    Jiang, Simon
    Wrigley, Jane
    Jones, Kelly
    Garland, Russell
    Williams, Neil
    Kumari, Rajendra
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [4] Evaluation of checkpoint inhibitors on tumour infiltrating immune cells in the orthotopic and metastatic tumour microenvironment using bioluminescent syngeneic cell line models
    McKenzie, Andrew
    Papadopoulou, Nektaria
    Jiang, Simon
    Wrigley, Jane
    Malhi, Sumanjeet
    King, Jason
    Jones, Kelly
    Williams, Neil
    Kumari, Rajendra
    CANCER RESEARCH, 2017, 77
  • [5] Interrogation of checkpoint inhibitors in bioluminescent orthotopic syngeneic models of hepatocellular carcinoma
    Papadopoulou, Nektaria
    Wainwright, Louise
    Lacey, Vicky
    Wrigley, Jane
    Wood, Jamie
    Malhi, Sumanjeet
    Woolley, Louise
    King, Jason
    Jiang, Simon
    Kumari, Rajendra
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [6] Cabozantinib in combination with anti-PD1 immune checkpoint inhibitor in syngeneic tumour mouse models
    Sparks, R.
    Rolland, S.
    Klinz, S.
    Meyer-Losic, F.
    Nakhle, J.
    Delille, R.
    de Boisferonc, M. Hillairet
    ANNALS OF ONCOLOGY, 2019, 30
  • [7] Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components
    Hsu, Sheng-Kai
    Jadhao, Mahendra
    Liao, Wei-Ting
    Chang, Wen-Tsan
    Hung, Chun-Tzu
    Chiu, Chien-Chih
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [8] Combination strategies with checkpoint immunotherapy and inducers of immunogenic cell death (ICD) in immune competent syngeneic models
    McKenzie, A.
    Papadopoulou, N.
    Yin, Y.
    Jiang, S.
    Wrigley, J.
    King, J.
    Garland, R.
    Williams, N.
    Kumari, R.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S111 - S112
  • [9] CD47 Inhibition Impairs the Growth of Orthotopic, Immune Competent Lung Tumour Models
    Lau, A. P. Y.
    Kubli, S. P.
    Wakeham, A.
    Mak, T. W.
    Thu, K. L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S557 - S558
  • [10] Syngeneic tumor mouse models vary in their response to different immune checkpoint inhibitor treatment
    Jantscheff, P.
    Schaefer-Obodozie, C.
    Moor, S.
    Weber, H.
    EUROPEAN JOURNAL OF CANCER, 2016, 55 : S11 - S11
12345